The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
Piperidolate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A03AA30
CAS registry number (Chemical Abstracts Service)
0000082-98-4
Chemical Formula
C21-H25-N-O2
Molecular Weight
323
Therapeutic Categories
Spasmolytic agent
Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)
Chemical Name
Benzeneacetic acid, α-phenyl-, 1-etyl-3-piperidinyl ester
Foreign Names
- Piperidolatum (Latin)
- Piperidolat (German)
- Pipéridolate (French)
- Piperidolato (Spanish)
Generic Names
- Piperidolate (OS: BAN)
- Pipéridolate (OS: DCF)
- Piperidolate Hydrochloride (OS: BANM, JAN)
- Piperidolate Hydrochloride (PH: USP XX)
Brand Names
- Dactil
Kissei Pharmaceutical, Japan - Dactil OB
Sanofi-Aventis, Mexico - Dactil-OB [+ Hesperidin, + Ascorbic Acid]
Sanofi-Aventis Farmaceutica, Brazil - Dactiran
Kyorin Pharmaceutical, Japan; Shinlin Sinseng, Taiwan - Licos
Meider, Taiwan
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.